Image pharmaphorum Editor News Tesaro stock rockets as rumours of Roche takeover abound Shares in US biotech Tesaro peaked this week amid speculation that Roche is making plans to buy it. News NICE says 'no' to Roche's Perjeta after breast cancer surger... NICE consulting on first draft decision News Roche to buy rest of genetics firm Foundation Medicine Roche has made an offer to buy the remaining shares in cancer genetics firm Foundation Medicine (FMI) for $2.4 billion. News Positive results announced for ViiV Healthcare's two-drug HI... A two-drug strategy has shown positive results, giving new hope to patients with HIV. Load more results
News Tesaro stock rockets as rumours of Roche takeover abound Shares in US biotech Tesaro peaked this week amid speculation that Roche is making plans to buy it.
News NICE says 'no' to Roche's Perjeta after breast cancer surger... NICE consulting on first draft decision
News Roche to buy rest of genetics firm Foundation Medicine Roche has made an offer to buy the remaining shares in cancer genetics firm Foundation Medicine (FMI) for $2.4 billion.
News Positive results announced for ViiV Healthcare's two-drug HI... A two-drug strategy has shown positive results, giving new hope to patients with HIV.
News UK spurs prescribing of obesity jab Mounjaro with GP bonus Doctors in the UK will be given thousands of pounds in bonus payments from April for prescribing Eli Lilly's weight-loss drug Mounjaro.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
